BioMarin to acquire Alesta Therapeutics for $275 million
Piotr Swat | Lightrocket | Getty Images CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose…
Morgan Stanley says these ‘dividend hopefuls’ are poised to outperform if they initiate a payout
Dividend stocks may help boost investor returns over time, and Morgan Stanley thinks a number of companies are…
Crispr gene editing treatment from Intellia succeeds in Phase 3 trial
Intellia Therapeutics, building exterior and company sign, Cambridge, Massachusetts, USA. Spencer Grant | Universal Images Group | Getty…